WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. (NASDAQ:BMET) reported today on a ruling issued this week by the United States Court of Appeals for the Federal Circuit in the ongoing patent infringement litigation between Cross Medical Products, Inc. (a Biomet subsidiary), Medtronic Sofamor Danek, Inc. and Medtronic Sofamor Danek USA, Inc.
